An  ||| S:0 E:3 ||| DT
evidence  ||| S:3 E:12 ||| NN
based  ||| S:12 E:18 ||| VBN
overview  ||| S:18 E:27 ||| VBN
of  ||| S:27 E:30 ||| IN
sublingual  ||| S:30 E:41 ||| JJ
immunotherapy  ||| S:41 E:55 ||| NN
in  ||| S:55 E:58 ||| IN
children  ||| S:58 E:67 ||| NNS
In  ||| S:67 E:70 ||| IN
light  ||| S:70 E:76 ||| NN
of  ||| S:76 E:79 ||| IN
the  ||| S:79 E:83 ||| DT
current  ||| S:83 E:91 ||| JJ
evidence ||| S:91 E:99 ||| NN
,  ||| S:99 E:101 ||| ,
subcutaneous  ||| S:101 E:114 ||| FW
immunotherapy  ||| S:114 E:128 ||| FW
( ||| S:128 E:129 ||| -LRB-
SCIT ||| S:129 E:133 ||| NNP
)  ||| S:133 E:135 ||| -RRB-
can  ||| S:135 E:139 ||| MD
be  ||| S:139 E:142 ||| VB
suggested  ||| S:142 E:152 ||| VBN
for  ||| S:152 E:156 ||| IN
use  ||| S:156 E:160 ||| NN
in  ||| S:160 E:163 ||| IN
pediatric  ||| S:163 E:173 ||| JJ
allergic  ||| S:173 E:182 ||| JJ
rhinitis  ||| S:182 E:191 ||| NN
and  ||| S:191 E:195 ||| CC
asthma  ||| S:195 E:202 ||| NN
as  ||| S:202 E:205 ||| IN
treatment  ||| S:205 E:215 ||| NN
and  ||| S:215 E:219 ||| CC
preventive  ||| S:219 E:230 ||| JJ
management ||| S:230 E:240 ||| NN
.  ||| S:240 E:242 ||| .
Sublingual  ||| S:242 E:253 ||| JJ
specific  ||| S:253 E:262 ||| JJ
immunotherapy  ||| S:262 E:276 ||| NNS
( ||| S:276 E:277 ||| -LRB-
SLIT ||| S:277 E:281 ||| NNP
)  ||| S:281 E:283 ||| -RRB-
can  ||| S:283 E:287 ||| MD
be  ||| S:287 E:290 ||| VB
suggested  ||| S:290 E:300 ||| VBN
for  ||| S:300 E:304 ||| IN
use  ||| S:304 E:308 ||| NN
in  ||| S:308 E:311 ||| IN
children  ||| S:311 E:320 ||| NNS
with  ||| S:320 E:325 ||| IN
allergic  ||| S:325 E:334 ||| JJ
rhino-conjunctivitis ||| S:334 E:354 ||| NN
,  ||| S:354 E:356 ||| ,
and  ||| S:356 E:360 ||| CC
seasonal  ||| S:360 E:369 ||| JJ
asthma ||| S:369 E:375 ||| NN
,  ||| S:375 E:377 ||| ,
especially  ||| S:377 E:388 ||| RB
if  ||| S:388 E:391 ||| IN
they  ||| S:391 E:396 ||| PRP
are  ||| S:396 E:400 ||| VBP
mono-sensitive ||| S:400 E:414 ||| JJ
,  ||| S:414 E:416 ||| ,
for  ||| S:416 E:420 ||| IN
a  ||| S:420 E:422 ||| DT
duration  ||| S:422 E:431 ||| NN
of  ||| S:431 E:434 ||| IN
no  ||| S:434 E:437 ||| DT
less  ||| S:437 E:442 ||| JJR
than  ||| S:442 E:447 ||| IN
three  ||| S:447 E:453 ||| CD
years ||| S:453 E:458 ||| NNS
.  ||| S:458 E:460 ||| .
The  ||| S:460 E:464 ||| DT
earlier  ||| S:464 E:472 ||| JJR
treatment  ||| S:472 E:482 ||| NN
begins ||| S:482 E:488 ||| VBZ
,  ||| S:488 E:490 ||| ,
the  ||| S:490 E:494 ||| DT
better  ||| S:494 E:501 ||| RB
is  ||| S:501 E:504 ||| VBZ
the  ||| S:504 E:508 ||| DT
outcome ||| S:508 E:515 ||| NN
.  ||| S:515 E:517 ||| .
Further  ||| S:517 E:525 ||| JJ
randomized ||| S:525 E:535 ||| NN
,  ||| S:535 E:537 ||| ,
long-term  ||| S:537 E:547 ||| JJ
trials  ||| S:547 E:554 ||| NNS
in  ||| S:554 E:557 ||| IN
SLIT  ||| S:557 E:562 ||| NNP
for  ||| S:562 E:566 ||| IN
the  ||| S:566 E:570 ||| DT
treatment  ||| S:570 E:580 ||| NN
of  ||| S:580 E:583 ||| IN
perennial  ||| S:583 E:593 ||| JJ
asthmatic  ||| S:593 E:603 ||| JJ
children  ||| S:603 E:612 ||| NNS
are  ||| S:612 E:616 ||| VBP
still  ||| S:616 E:622 ||| RB
needed ||| S:622 E:628 ||| VBN
.  ||| S:628 E:630 ||| .
As  ||| S:630 E:633 ||| RB
regards  ||| S:633 E:641 ||| VBZ
the  ||| S:641 E:645 ||| DT
choice  ||| S:645 E:652 ||| NN
between  ||| S:652 E:660 ||| IN
the  ||| S:660 E:664 ||| DT
methods  ||| S:664 E:672 ||| NNS
of  ||| S:672 E:675 ||| IN
administration  ||| S:675 E:690 ||| NN
( ||| S:690 E:691 ||| -LRB-
the  ||| S:691 E:695 ||| DT
traditional  ||| S:695 E:707 ||| JJ
SCIT  ||| S:707 E:712 ||| NNP
or  ||| S:712 E:715 ||| CC
the  ||| S:715 E:719 ||| DT
innovative  ||| S:719 E:730 ||| JJ
SLIT ||| S:730 E:734 ||| NNP
) ||| S:734 E:735 ||| -RRB-
,  ||| S:735 E:737 ||| ,
it  ||| S:737 E:740 ||| PRP
is  ||| S:740 E:743 ||| VBZ
up  ||| S:743 E:746 ||| RP
to  ||| S:746 E:749 ||| TO
the  ||| S:749 E:753 ||| DT
physician  ||| S:753 E:763 ||| NN
to  ||| S:763 E:766 ||| TO
find  ||| S:766 E:771 ||| VB
the  ||| S:771 E:775 ||| DT
right  ||| S:775 E:781 ||| JJ
equilibrium  ||| S:781 E:793 ||| NN
in  ||| S:793 E:796 ||| IN
the  ||| S:796 E:800 ||| DT
single  ||| S:800 E:807 ||| JJ
patient ||| S:807 E:814 ||| NN
.  ||| S:814 E:816 ||| .
